184 related articles for article (PubMed ID: 18090495)
1. Imaging low-risk prostate cancer.
Shukla-Dave A; Hricak H; Scardino PT
Curr Opin Urol; 2008 Jan; 18(1):78-86. PubMed ID: 18090495
[TBL] [Abstract][Full Text] [Related]
2. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
3. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.
Shukla-Dave A; Hricak H; Kattan MW; Pucar D; Kuroiwa K; Chen HN; Spector J; Koutcher JA; Zakian KL; Scardino PT
BJU Int; 2007 Apr; 99(4):786-93. PubMed ID: 17223922
[TBL] [Abstract][Full Text] [Related]
4. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy.
Fuchsjäger MH; Shukla-Dave A; Hricak H; Wang L; Touijer K; Donohue JF; Eastham JA; Kattan MW
BJU Int; 2009 Aug; 104(3):315-20. PubMed ID: 19220263
[TBL] [Abstract][Full Text] [Related]
6. [Current role of MRI for the local staging of prostate cancer].
Busquets JC; Batlle JC; Obregón JB; Ortega MV; Morell NR
Arch Esp Urol; 2006 Dec; 59(10):1001-10. PubMed ID: 17283713
[TBL] [Abstract][Full Text] [Related]
7. Inventory of prostate cancer predictive tools.
Shariat SF; Karakiewicz PI; Margulis V; Kattan MW
Curr Opin Urol; 2008 May; 18(3):279-96. PubMed ID: 18382238
[TBL] [Abstract][Full Text] [Related]
8. A catalog of prostate cancer nomograms.
Ross PL; Scardino PT; Kattan MW
J Urol; 2001 May; 165(5):1562-8. PubMed ID: 11342918
[TBL] [Abstract][Full Text] [Related]
9. Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer.
Shukla-Dave A; Hricak H; Akin O; Yu C; Zakian KL; Udo K; Scardino PT; Eastham J; Kattan MW
BJU Int; 2012 May; 109(9):1315-22. PubMed ID: 21933336
[TBL] [Abstract][Full Text] [Related]
10. Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease.
Dall'era MA; Hosang N; Konety B; Cowan JE; Carroll PR
J Urol; 2009 Apr; 181(4):1622-7; discussion 1627. PubMed ID: 19230923
[TBL] [Abstract][Full Text] [Related]
11. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.
Lawrentschuk N; Fleshner N
BJU Int; 2009 Mar; 103(6):730-3. PubMed ID: 19154475
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer.
Huzjan R; Sala E; Hricak H
Nat Clin Pract Urol; 2005 Sep; 2(9):434-42. PubMed ID: 16474681
[TBL] [Abstract][Full Text] [Related]
13. MRI and surveillance.
Ouzzane A; Puech P; Villers A
Curr Opin Urol; 2012 May; 22(3):231-6. PubMed ID: 22388665
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging.
Casciani E; Gualdi GF
Abdom Imaging; 2006; 31(4):490-9. PubMed ID: 16955379
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer imaging--what the urologic oncologist needs to know.
Ross R; Harisinghani M
Radiol Clin North Am; 2006 Sep; 44(5):711-22, viii. PubMed ID: 17030222
[TBL] [Abstract][Full Text] [Related]
16. Functional magnetic resonance imaging in prostate cancer.
Seitz M; Shukla-Dave A; Bjartell A; Touijer K; Sciarra A; Bastian PJ; Stief C; Hricak H; Graser A
Eur Urol; 2009 Apr; 55(4):801-14. PubMed ID: 19185981
[TBL] [Abstract][Full Text] [Related]
17. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O
Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.
Ito K
Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365
[TBL] [Abstract][Full Text] [Related]
19. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging.
Vilanova JC; Barceló J
Abdom Imaging; 2007; 32(2):253-61. PubMed ID: 17476554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
